This product contains information from the British National Formulary (BNF). For more comprehensive prescribing and drug information, refer to the complete current edition of the British National Formulary or www.bnf.org.

The BNF is jointly owned by the Royal Pharmaceutical Society of Great Britain and the BMJ Publishing Group Ltd (jointly referred to as “The Publisher”). The BNF provides UK healthcare professionals with authoritative and practical information on the selection and clinical use of medicines in a clear, concise and accessible manner. The BNF is designed for prescribers, pharmacists and other healthcare professionals, situated within the United Kingdom.  The Publisher works to ensure that the information provided in the BNF is accurate and up-to-date as at the date of publication, but changes do regularly occur and the Publisher does not warrant that it is accurate.

The BNF is designed as a digest for rapid reference and it may not always include all information necessary for prescribing or dispensing. Also less detail is given on certain specialties since those involved are expected to have specialist knowledge and access to specialist literature. The BNF should be interpreted in light of professional knowledge and supplemented as necessary with specialist publications and by reference to product literature. Information is also available from medicines information services. 

To the fullest extent permitted by law the Publisher assumes no responsibility for any aspect of healthcare administered with the aid of this information or any other use of this information. The Publisher does not exclude any liability for death or personal injury resulting from negligence, fraud, or any liability which cannot be excluded by applicable law.


The use of this website is subject to the disclaimer and terms and conditions set out below. By using this website you agree to be bound by these terms and conditions.

The guidance presented in this website is based on information contained in the British National Formulary (BNF) and BNF for Children (BNFC) and the opinion of experts and experienced practitioners, and reflects current relevant legislation and professional regulations. It should be used in conjunctions with the BNF and BNFC and be taken into account when making decisions about a particular clinical procedure or treatment plan in discussion with the patient and/or guardian or carer. As guidance, the information presented here does not override the individual responsibility of the health professional to make decisions appropriate to the individual patient. However, it is advised that significant departures from this guidance be fully documented in the patient’s case notes at the time the relevant decision is made.

SDCEP makes every effort to ensure the accuracy of the prescribing information contained in Drug Prescribing for Dentistry and endeavours to keep it up to date with changes in the BNF and BNFC. However, SDCEP cannot guarantee its correctness and completeness at all times. SDCEP will not be held liable for information that is inaccurate. SDCEP does not accept responsibility for any loss, damage or expense resulting from the use of this guidance.

All links from this website are provided for information and convenience only. SDCEP cannot accept responsibility for the sites linked to, or the information found there. SDCEP cannot guarantee uninterrupted access to the sites to which this website links.